Market News
7 min read | Updated on September 23, 2024, 14:51 IST
SUMMARY
On Monday, the NIFTY50 index traded above the level of 25,900. Dhampur Bio Organics hit a 20% upper circuit, while RattanIndia Power, Aurionpro Solutions, PC Jeweller, Tribhovandas Bhimji Zaveri, Unitech and Reliance Power hit a 5% upper circuit. GE T&D India and Panacea Biotec hit a 5% lower circuit.
Stock list
Dhampur Bio Organics, RattanIndia Power, Aurionpro Solutions, PC Jeweller, Tribhovandas Bhimji Zaveri, Unitech and Reliance Power hit the upper circuit, while GE T&D India and Panacea Biotec hit the lower circuit today
Domestic equity bourses, NIFTY50 and SENSEX are trading in the green, advancing by 0.34% and 0.23%, respectively. The Nifty Midcap 100 index and the Nifty Smallcap 100 index are trading positively, up by 0.54% and 0.77% respectively.
On the NSE, 117 stocks hit the upper price band (Upper Circuit), and 52 stocks hit the lower price band (Lower Circuit).
Here is the list of stocks (market cap above ₹1,000 crore) locked in upper and lower circuits in today’s trading session.
Incorporated in 2022, Dhampur Bio Organics manufactures sugar, chemicals, ethanol, co-generation of power and other allied products. The company has a market capitalisation of ₹1,020 crore. It is focused on repositioning itself as a value-added sugar manufacturer on one hand and a bio-energy company on the other. The three manufacturing facilities – in Asmoli, Mansurpur and Meerganj; are strategically located close to each other enabling better utilisation of resources and increased synergies in production and management.
The company has a market capitalisation of ₹9,400 crore. In the last one year, the stock has surged by 170%.
Recently, the company declared strong financial results for Q1FY25. In the quarter, the company reported a 505.67% increase in total income from ₹72.61 crore in Q1FY24 to ₹439.78 crore. PAT increased from a net loss of ₹171.62 crore in Q1FY24 to ₹156.06 crore. After six consecutive quarters of loss-making, the company generated profits this quarter.
Additionally, the company has settled its outstanding dues through One-Time Settlement (OTS) from many banks, including IDBI Bank, IDFC First Bank, Indian Bank, Indian Overseas Bank, Bank of Baroda, IndusInd Bank, and Canara Bank. PC Jeweller manufactures, sells, and trades gold, diamond-studded, and silver jewellery and operates in different geographical areas. The company has a market capitalisation of ₹6,800 crore and has surged 451% in shares in the last year.
Incorporated in 2007, Tribhovandas Bhimji Zaveri (TBZ) is in the business of retail sales of ornaments made of gold, diamond, silver, platinum and precious stones. The company has a market capitalisation of ₹1,900 crore and over the past six months, shares have surged by 167%.
The company has a market capitalisation of ₹3,000 crore and over the past one year company shares have surged by 240%.
Reliance Infrastructure, which held a 23.15% stake in Reliance Power as of June 30, advanced by 45% over the last one week. Reliance Power has been established to develop, construct and operate power projects in India and internationally. The company has a market capitalisation of ₹15,300 crore and over the past one year company shares have surged by 102%.
The floor price of the offer will be ₹1,400 per equity share. The OFS involves up to 11.7% of the company’s equity share capital, which amounts to 30 million shares. Each share has a face value of ₹2. The promoters have also included an oversubscription option to sell an additional 3.9% of equity, representing 10 million shares, which could increase the total sale to 15.6% of the company’s paid-up equity share capital, if fully exercised. This means the total potential offer size could reach 40 million shares.
GE T&D India is the entity that runs GE Vernova’s Electrification business in India. It has been in the power transmission and distribution business for more than 100 years and provides a versatile range of solutions for connecting and evacuating power from generation sources onto the grid. It has a market capitalisation of ₹38,800 crore.
Panacea Biotec is a global pharmaceutical and vaccine manufacturer based in New Delhi, Mumbai, and Lalru. The company researches, develops, manufactures, and markets pharmaceuticals, vaccines, biosimilars, and natural products.
Over the past three months, the company's shares have surged as currently India lacks an antiviral treatment or licensed vaccine for dengue. Panacea Biotec is working on a dengue vaccine, which has been in development since 2006.
Additionally, the company recently announced the settlement of a legal dispute with Sanofi Healthcare India Private Limited (Sanofi). On May 17, 2021, Panacea Biotec filed a lawsuit in the Delhi High Court to prevent Sanofi from marketing a fully liquid hexavalent vaccine that would infringe on Panacea’s patent for its wP-IPV based fully liquid hexavalent vaccine, EasySix. The company has a market capitalisation of ₹1,900 crore.
About The Author
Next Story